Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of Bortezomib in Preclinical Models of Multiple Myeloma - Concepedia

Concepedia

Publication | Open Access

Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of Bortezomib in Preclinical Models of Multiple Myeloma

DOI Full Paper Access

115

Citations

38

References

2007

Year

Peter M. Voorhees, Qing Chen, Deborah J. Kuhn, George W. Small, Sally A. Hunsucker, John S. Strader, Robert Corringham, Mohamed H. Zaki, Jeffrey A. Nemeth, Robert Z. Orlowski

Clinical Cancer Research

Abstract

Taken together, our results provide a strong preclinical rationale for the clinical development of the bortezomib/CNTO 328 combination for patients with myeloma.

References

	Year	Citations

Page 1